Literature DB >> 25516637

Health care-associated hepatitis C virus infection.

Bruno Pozzetto1, Meriam Memmi1, Olivier Garraud1, Xavier Roblin1, Philippe Berthelot1.   

Abstract

Hepatitis C virus (HCV) is a blood-borne pathogen that has a worldwide distribution and infects millions of people. Care-associated HCV infections represented a huge part of hepatitis C burden in the past via contaminated blood and unsafe injections and continue to be a serious problem of public health. The present review proposes a panorama of health care-associated HCV infections via the three mode of contamination that have been identified: (1) infected patient to non-infected patient; (2) infected patient to non-infected health care worker (HCW); and (3) infected HCW to non infected patient. For each condition, the circumstances of contamination are described together with the means to prevent them. As a whole, the more important risk is represented by unsafe practices regarding injections, notably with the improper use of multidose vials used for multiple patients. The questions of occupational exposures and infected HCWs are also discussed. In terms of prevention and surveillance, the main arm for combating care-associated HCV infections is the implementation of standard precautions in all the fields of cares, with training programs and audits to verify their good application. HCWs must be sensitized to the risk of blood-borne pathogens, notably by the use of safety devices for injections and good hygiene practices in the operating theatre and in all the invasive procedures. The providers performing exposed-prone procedures must monitor their HCV serology regularly in order to detect early any primary infection and to treat it without delay. With the need to stay vigilant because HCV infection is often a hidden risk, it can be hoped that the number of people infected by HCV via health care will decrease very significantly in the next years.

Entities:  

Keywords:  Antiviral drugs; Health care worker; Health care-associated infection; Hemodialysis; Hepatitis C virus; Occupational exposure; Standard precautions; Unsafe injections

Mesh:

Substances:

Year:  2014        PMID: 25516637      PMCID: PMC4265584          DOI: 10.3748/wjg.v20.i46.17265

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  103 in total

1.  The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.

Authors:  Joseph F Perz; Gregory L Armstrong; Leigh A Farrington; Yvan J F Hutin; Beth P Bell
Journal:  J Hepatol       Date:  2006-06-23       Impact factor: 25.083

2.  Behavioural predictors of subsequent hepatitis C diagnosis in a UK clinic sample of HIV positive men who have sex with men.

Authors:  J M Turner; A T Rider; J Imrie; A J Copas; S G Edwards; J P Dodds; J M Stephenson
Journal:  Sex Transm Infect       Date:  2006-08       Impact factor: 3.519

3.  Prevalence of hepatitis C virus infection among men who have sex with men at a Boston community health center and its association with markers of high-risk behavior.

Authors:  Daniel E Cohen; Christopher J Russell; Sarit A Golub; Kenneth H Mayer
Journal:  AIDS Patient Care STDS       Date:  2006-08       Impact factor: 5.078

Review 4.  European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus.

Authors:  V Puro; G De Carli; S Cicalini; F Soldani; U Balslev; J Begovac; L Boaventura; M Campins Martí; M J Hernández Navarrete; R Kammerlander; C Larsen; F Lot; S Lunding; U Marcus; L Payne; A A Pereira; T Thomas; G Ippolito
Journal:  Euro Surveill       Date:  2005-10

5.  Hepatitis C virus transmission from a healthcare worker to a patient.

Authors:  Florence Lot; Elisabeth Delarocque-Astagneau; Valérie Thiers; Claude Bernet; François Rimlinger; Jean-Claude Desenclos; Pascal Chaud; Françoise Dumay
Journal:  Infect Control Hosp Epidemiol       Date:  2007-01-26       Impact factor: 3.254

6.  Infectivity of hepatitis C virus in plasma after drying and storing at room temperature.

Authors:  Saleem Kamili; Kris Krawczynski; Karen McCaustland; Xiaofang Li; Miriam J Alter
Journal:  Infect Control Hosp Epidemiol       Date:  2007-04-16       Impact factor: 3.254

Review 7.  Epidemiology of hepatitis virus B and C.

Authors:  Margarita Dehesa-Violante; Rafael Nuñez-Nateras
Journal:  Arch Med Res       Date:  2007-08       Impact factor: 2.235

8.  The epidemiology and virology of hepatitis C virus genotype 5 in central France.

Authors:  A Abergel; S Ughetto; S Dubost; C Bonny; B Aublet-Cuvelier; E Delarocque-Astagneau; J L Bailly; G Bommelaer; S Casanova; J Delteil; P Deny; H Laurichesse; H Odent-Malaure; J Roussel; H Peigue-Lafeuille; C Henquell
Journal:  Aliment Pharmacol Ther       Date:  2007-09-26       Impact factor: 8.171

9.  Iatrogenic transmission of hepatitis C virus (HCV) by an anesthesiologist: comparative molecular analysis of the HCV-E1 and HCV-E2 hypervariable regions.

Authors:  Yonat Shemer-Avni; Michal Cohen; Ayelet Keren-Naus; Emanuel Sikuler; Negba Hanuka; Arie Yaari; Eithan Hayam; Larisa Bachmatov; Romy Zemel; Ran Tur-Kaspa
Journal:  Clin Infect Dis       Date:  2007-07-10       Impact factor: 9.079

10.  Efficacy and safety of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.

Authors:  Celal Ayaz; Mustafa Kemal Celen; Ugur Nedim Yuce; Mehmet Faruk Geyik
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

View more
  10 in total

1.  No longer 'written off' - times have changed for the BBV-infected dental professional.

Authors:  J Bagg; K Roy; L Hopps; I Black; D Croser; C O'Halloran; F Ncube
Journal:  Br Dent J       Date:  2017-01-13       Impact factor: 1.626

2.  Trends in hepatitis B and hepatitis C seroprevalence among blood donors - Haiti, 2005-2014.

Authors:  A E Jean Baptiste; M S Chevalier; E Polo; E Noel; E N Hulland; W R Archer
Journal:  ISBT Sci Ser       Date:  2018-03-22

3.  NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients.

Authors:  Maria Concetta Bellocchi; Marianna Aragri; Luca Carioti; Lavinia Fabeni; Rosaria Maria Pipitone; Giuseppina Brancaccio; Maria Chiara Sorbo; Silvia Barbaliscia; Velia Chiara Di Maio; Fabrizio Bronte; Stefania Grimaudo; Walter Mazzucco; Ferdinando Frigeri; Marco Cantone; Antonio Pinto; Carlo Federico Perno; Antonio Craxì; Giovanni Battista Gaeta; Vito Di Marco; Francesca Ceccherini-Silberstein
Journal:  Cells       Date:  2019-07-02       Impact factor: 6.600

Review 4.  Epidemiology, risk factors, and pathogenesis associated with a superbug: A comprehensive literature review on hepatitis C virus infection.

Authors:  Mehlayl Tariq; Abu Bakar Shoukat; Sedrah Akbar; Samaia Hameed; Muniba Zainab Naqvi; Ayesha Azher; Muhammad Saad; Muhammad Rizwan; Muhammad Nadeem; Anum Javed; Asad Ali; Shahid Aziz
Journal:  SAGE Open Med       Date:  2022-06-29

5.  Meta-analysis: risk of hepatitis C virus infection associated with hospital-based invasive procedures.

Authors:  Paul Henriot; Mathieu Castry; Liem Binh Luong Nguyen; Yusuke Shimakawa; Kévin Jean; Laura Temime
Journal:  Aliment Pharmacol Ther       Date:  2022-06-27       Impact factor: 9.524

6.  Detection of hepatitis C virus (HCV) among health care providers in an Egyptian university hospital: different diagnostic modalities.

Authors:  Rehab H El-Sokkary; Rehab M Elsaid Tash; Takwa E Meawed; Omnia S El Seifi; Eman M Mortada
Journal:  Infect Drug Resist       Date:  2017-10-17       Impact factor: 4.003

7.  Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography.

Authors:  Eyal Shteyer; Louis Shekhtman; Tal Zinger; Sheri Harari; Inna Gafanovich; Dana Wolf; Hefziba Ivgi; Rima Barsuk; Ilana Dery; Daniela Armoni; Mila Rivkin; Rahul Pipalia; Michal Cohen Eliav; Yizhak Skorochod; Gabriel S Breuer; Ran Tur-Kaspa; Yonit Weil Wiener; Adi Stern; Scott J Cotler; Harel Dahari; Yoav Lurie
Journal:  PLoS One       Date:  2019-01-15       Impact factor: 3.240

8.  Assessment of Knowledge About the Risk Factors of Chronic Liver Disease in Patients Admitted in Civil Hospital Karachi.

Authors:  Bushra Majid; Rimsha Khan; Zainab Junaid; Onaiza Khurshid; Syeda Hajrah Rehman; Syeda Naintara Jaffri; Batool Zaidi; Jabeen Zehra; Sabika Batool; Saman Altaf; Aliya Jatoi; Fatima Safina
Journal:  Cureus       Date:  2019-10-20

9.  Effectiveness of direct-acting antivirals in maintenance hemodialysis patients complicated with chronic hepatitis C.

Authors:  Chunhong Li; Jing Liang; Huiling Xiang; Haiyan Chen; Jie Tian
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.817

10.  Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits.

Authors:  Nick Scott; Thin Mar Win; Tom Tidhar; Hla Htay; Bridget Draper; Phyo Thu Zar Aung; Yinzong Xiao; Anna Bowring; Christian Kuschel; Sonjelle Shilton; Khin Pyone Kyi; Win Naing; Khin Sanda Aung; Margaret Hellard
Journal:  Lancet Reg Health West Pac       Date:  2021-03-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.